Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species
The Burkholderia cepacia complex (Bcc) is a group of 17 closely related species of the β-proteobacteria subdivision that emerged in the 1980s as important human pathogens, especially to patients suffering from cystic fibrosis. Since then, a remarkable progress has been achieved on the taxonomy and m...
Gespeichert in:
Veröffentlicht in: | Applied microbiology and biotechnology 2010-06, Vol.87 (1), p.31-40 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 40 |
---|---|
container_issue | 1 |
container_start_page | 31 |
container_title | Applied microbiology and biotechnology |
container_volume | 87 |
creator | Leitão, Jorge H Sousa, Sílvia A Ferreira, Ana S Ramos, Christian G Silva, Inês N Moreira, Leonilde M |
description | The Burkholderia cepacia complex (Bcc) is a group of 17 closely related species of the β-proteobacteria subdivision that emerged in the 1980s as important human pathogens, especially to patients suffering from cystic fibrosis. Since then, a remarkable progress has been achieved on the taxonomy and molecular identification of these bacteria. Although some progress have been achieved on the knowledge of the pathogenesis traits and virulence factors used by these bacteria, further work envisaging the identification of potential targets for the scientifically based design of new therapeutic strategies is urgently needed, due to the very difficult eradication of these bacteria with available therapies. An overview of these aspects of Bcc pathogenesis and opportunities for the design of future therapies is presented and discussed in this work. |
doi_str_mv | 10.1007/s00253-010-2528-0 |
format | Article |
fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_746227803</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A623955049</galeid><sourcerecordid>A623955049</sourcerecordid><originalsourceid>FETCH-LOGICAL-c600t-94ca18d264f6b5cdb498ccbd394e3397d5ed0a11cda8b15f29ca46d862765d813</originalsourceid><addsrcrecordid>eNqFkl1rFDEUhgdR7Fr9Ad7ooIgInXryOZnLWqoWCoq11yGbZGZTZydjkpEW_PHNdlbLiii5OJA87xMS3qJ4iuAQAdRvIwBmpAIEFWZYVHCvWCBKcAUc0fvFAlDNqpo1Yq94FOMlAMKC84fFHgbSAEVsUfz8rNLKd3Zw2qXrg_KHC1NvB23LVunkQzwo1WDKmIJKtnM2lsmXretWqVSdckNM5bspfFv53tjgVKntqPRm-vXY26ty3OrjrSbYPmuybrQ6ux4XD1rVR_tkO_eLi_cnX48_VmefPpweH51VmgOkqqFaIWEwpy1fMm2WtBFaLw1pqCWkqQ2zBhRC2iixRKzFjVaUG8FxzZkRiOwXr2fvGPz3ycYk1y5q2_dqsH6KsqYc41oA-T9JCGNCEJzJF3-Ql34KQ36GJEA5EvxW93KGOtVb6YbW53_UG6U84pg0jAFtMnX4FyovY9dO-8G2Lu_vBN7sBDKT7FXq1BSjPD3_ssuimdXBxxhsK8fg1ipcSwRy0yI5t0jmFslNiyTkzLPt26bl2prfiV-1ycCrLaCiVn0b1KBdvOOwaIBxkTk8czEfDZ0Nd5_0r9ufz6FWeam6kMUX5xgQASQowwSRG0L45qU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>304618603</pqid></control><display><type>article</type><title>Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Leitão, Jorge H ; Sousa, Sílvia A ; Ferreira, Ana S ; Ramos, Christian G ; Silva, Inês N ; Moreira, Leonilde M</creator><creatorcontrib>Leitão, Jorge H ; Sousa, Sílvia A ; Ferreira, Ana S ; Ramos, Christian G ; Silva, Inês N ; Moreira, Leonilde M</creatorcontrib><description>The Burkholderia cepacia complex (Bcc) is a group of 17 closely related species of the β-proteobacteria subdivision that emerged in the 1980s as important human pathogens, especially to patients suffering from cystic fibrosis. Since then, a remarkable progress has been achieved on the taxonomy and molecular identification of these bacteria. Although some progress have been achieved on the knowledge of the pathogenesis traits and virulence factors used by these bacteria, further work envisaging the identification of potential targets for the scientifically based design of new therapeutic strategies is urgently needed, due to the very difficult eradication of these bacteria with available therapies. An overview of these aspects of Bcc pathogenesis and opportunities for the design of future therapies is presented and discussed in this work.</description><identifier>ISSN: 0175-7598</identifier><identifier>EISSN: 1432-0614</identifier><identifier>DOI: 10.1007/s00253-010-2528-0</identifier><identifier>PMID: 20390415</identifier><identifier>CODEN: AMBIDG</identifier><language>eng</language><publisher>Berlin/Heidelberg: Berlin/Heidelberg : Springer-Verlag</publisher><subject>Animals ; Antimicrobial agents ; Bacteria ; Biological and medical sciences ; Biomedical and Life Sciences ; Biotechnology ; Burkholderia cepacia ; Burkholderia cepacia complex ; Burkholderia cepacia complex - classification ; Burkholderia cepacia complex - drug effects ; Burkholderia cepacia complex - genetics ; Burkholderia cepacia complex - pathogenicity ; Burkholderia Infections - microbiology ; Burkholderia Infections - therapy ; Cystic fibrosis ; Disease Models, Animal ; Drug resistance ; Drug Resistance, Bacterial ; Enzymes ; Fundamental and applied biological sciences. Psychology ; Genomes ; Health aspects ; Humans ; Identification ; Infections ; Laboratories ; Life Sciences ; Microbial Genetics and Genomics ; Microbiology ; Mini-Review ; Pathogenesis ; Pathogenic microorganisms ; pathogenicity ; Pathogens ; Patients ; Plasmids ; Studies ; Taxonomy ; Virulence ; Virulence (Microbiology) ; Virulence Factors - antagonists & inhibitors ; Virulence Factors - genetics ; Virulence Factors - metabolism</subject><ispartof>Applied microbiology and biotechnology, 2010-06, Vol.87 (1), p.31-40</ispartof><rights>Springer-Verlag 2010</rights><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2010 Springer</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c600t-94ca18d264f6b5cdb498ccbd394e3397d5ed0a11cda8b15f29ca46d862765d813</citedby><cites>FETCH-LOGICAL-c600t-94ca18d264f6b5cdb498ccbd394e3397d5ed0a11cda8b15f29ca46d862765d813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00253-010-2528-0$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00253-010-2528-0$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22890568$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20390415$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Leitão, Jorge H</creatorcontrib><creatorcontrib>Sousa, Sílvia A</creatorcontrib><creatorcontrib>Ferreira, Ana S</creatorcontrib><creatorcontrib>Ramos, Christian G</creatorcontrib><creatorcontrib>Silva, Inês N</creatorcontrib><creatorcontrib>Moreira, Leonilde M</creatorcontrib><title>Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species</title><title>Applied microbiology and biotechnology</title><addtitle>Appl Microbiol Biotechnol</addtitle><addtitle>Appl Microbiol Biotechnol</addtitle><description>The Burkholderia cepacia complex (Bcc) is a group of 17 closely related species of the β-proteobacteria subdivision that emerged in the 1980s as important human pathogens, especially to patients suffering from cystic fibrosis. Since then, a remarkable progress has been achieved on the taxonomy and molecular identification of these bacteria. Although some progress have been achieved on the knowledge of the pathogenesis traits and virulence factors used by these bacteria, further work envisaging the identification of potential targets for the scientifically based design of new therapeutic strategies is urgently needed, due to the very difficult eradication of these bacteria with available therapies. An overview of these aspects of Bcc pathogenesis and opportunities for the design of future therapies is presented and discussed in this work.</description><subject>Animals</subject><subject>Antimicrobial agents</subject><subject>Bacteria</subject><subject>Biological and medical sciences</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Burkholderia cepacia</subject><subject>Burkholderia cepacia complex</subject><subject>Burkholderia cepacia complex - classification</subject><subject>Burkholderia cepacia complex - drug effects</subject><subject>Burkholderia cepacia complex - genetics</subject><subject>Burkholderia cepacia complex - pathogenicity</subject><subject>Burkholderia Infections - microbiology</subject><subject>Burkholderia Infections - therapy</subject><subject>Cystic fibrosis</subject><subject>Disease Models, Animal</subject><subject>Drug resistance</subject><subject>Drug Resistance, Bacterial</subject><subject>Enzymes</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Genomes</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Identification</subject><subject>Infections</subject><subject>Laboratories</subject><subject>Life Sciences</subject><subject>Microbial Genetics and Genomics</subject><subject>Microbiology</subject><subject>Mini-Review</subject><subject>Pathogenesis</subject><subject>Pathogenic microorganisms</subject><subject>pathogenicity</subject><subject>Pathogens</subject><subject>Patients</subject><subject>Plasmids</subject><subject>Studies</subject><subject>Taxonomy</subject><subject>Virulence</subject><subject>Virulence (Microbiology)</subject><subject>Virulence Factors - antagonists & inhibitors</subject><subject>Virulence Factors - genetics</subject><subject>Virulence Factors - metabolism</subject><issn>0175-7598</issn><issn>1432-0614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNqFkl1rFDEUhgdR7Fr9Ad7ooIgInXryOZnLWqoWCoq11yGbZGZTZydjkpEW_PHNdlbLiii5OJA87xMS3qJ4iuAQAdRvIwBmpAIEFWZYVHCvWCBKcAUc0fvFAlDNqpo1Yq94FOMlAMKC84fFHgbSAEVsUfz8rNLKd3Zw2qXrg_KHC1NvB23LVunkQzwo1WDKmIJKtnM2lsmXretWqVSdckNM5bspfFv53tjgVKntqPRm-vXY26ty3OrjrSbYPmuybrQ6ux4XD1rVR_tkO_eLi_cnX48_VmefPpweH51VmgOkqqFaIWEwpy1fMm2WtBFaLw1pqCWkqQ2zBhRC2iixRKzFjVaUG8FxzZkRiOwXr2fvGPz3ycYk1y5q2_dqsH6KsqYc41oA-T9JCGNCEJzJF3-Ql34KQ36GJEA5EvxW93KGOtVb6YbW53_UG6U84pg0jAFtMnX4FyovY9dO-8G2Lu_vBN7sBDKT7FXq1BSjPD3_ssuimdXBxxhsK8fg1ipcSwRy0yI5t0jmFslNiyTkzLPt26bl2prfiV-1ycCrLaCiVn0b1KBdvOOwaIBxkTk8czEfDZ0Nd5_0r9ufz6FWeam6kMUX5xgQASQowwSRG0L45qU</recordid><startdate>20100601</startdate><enddate>20100601</enddate><creator>Leitão, Jorge H</creator><creator>Sousa, Sílvia A</creator><creator>Ferreira, Ana S</creator><creator>Ramos, Christian G</creator><creator>Silva, Inês N</creator><creator>Moreira, Leonilde M</creator><general>Berlin/Heidelberg : Springer-Verlag</general><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PHGZM</scope><scope>PHGZT</scope><scope>PJZUB</scope><scope>PKEHL</scope><scope>PPXIY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQGLB</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>Q9U</scope><scope>7X8</scope><scope>7QO</scope></search><sort><creationdate>20100601</creationdate><title>Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species</title><author>Leitão, Jorge H ; Sousa, Sílvia A ; Ferreira, Ana S ; Ramos, Christian G ; Silva, Inês N ; Moreira, Leonilde M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c600t-94ca18d264f6b5cdb498ccbd394e3397d5ed0a11cda8b15f29ca46d862765d813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Animals</topic><topic>Antimicrobial agents</topic><topic>Bacteria</topic><topic>Biological and medical sciences</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Burkholderia cepacia</topic><topic>Burkholderia cepacia complex</topic><topic>Burkholderia cepacia complex - classification</topic><topic>Burkholderia cepacia complex - drug effects</topic><topic>Burkholderia cepacia complex - genetics</topic><topic>Burkholderia cepacia complex - pathogenicity</topic><topic>Burkholderia Infections - microbiology</topic><topic>Burkholderia Infections - therapy</topic><topic>Cystic fibrosis</topic><topic>Disease Models, Animal</topic><topic>Drug resistance</topic><topic>Drug Resistance, Bacterial</topic><topic>Enzymes</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Genomes</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Identification</topic><topic>Infections</topic><topic>Laboratories</topic><topic>Life Sciences</topic><topic>Microbial Genetics and Genomics</topic><topic>Microbiology</topic><topic>Mini-Review</topic><topic>Pathogenesis</topic><topic>Pathogenic microorganisms</topic><topic>pathogenicity</topic><topic>Pathogens</topic><topic>Patients</topic><topic>Plasmids</topic><topic>Studies</topic><topic>Taxonomy</topic><topic>Virulence</topic><topic>Virulence (Microbiology)</topic><topic>Virulence Factors - antagonists & inhibitors</topic><topic>Virulence Factors - genetics</topic><topic>Virulence Factors - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Leitão, Jorge H</creatorcontrib><creatorcontrib>Sousa, Sílvia A</creatorcontrib><creatorcontrib>Ferreira, Ana S</creatorcontrib><creatorcontrib>Ramos, Christian G</creatorcontrib><creatorcontrib>Silva, Inês N</creatorcontrib><creatorcontrib>Moreira, Leonilde M</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Global (Alumni Edition)</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Business Premium Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Global</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest Central (New)</collection><collection>ProQuest One Academic (New)</collection><collection>ProQuest Health & Medical Research Collection</collection><collection>ProQuest One Academic Middle East (New)</collection><collection>ProQuest One Health & Nursing</collection><collection>ProQuest One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Applied & Life Sciences</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>Biotechnology Research Abstracts</collection><jtitle>Applied microbiology and biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Leitão, Jorge H</au><au>Sousa, Sílvia A</au><au>Ferreira, Ana S</au><au>Ramos, Christian G</au><au>Silva, Inês N</au><au>Moreira, Leonilde M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species</atitle><jtitle>Applied microbiology and biotechnology</jtitle><stitle>Appl Microbiol Biotechnol</stitle><addtitle>Appl Microbiol Biotechnol</addtitle><date>2010-06-01</date><risdate>2010</risdate><volume>87</volume><issue>1</issue><spage>31</spage><epage>40</epage><pages>31-40</pages><issn>0175-7598</issn><eissn>1432-0614</eissn><coden>AMBIDG</coden><abstract>The Burkholderia cepacia complex (Bcc) is a group of 17 closely related species of the β-proteobacteria subdivision that emerged in the 1980s as important human pathogens, especially to patients suffering from cystic fibrosis. Since then, a remarkable progress has been achieved on the taxonomy and molecular identification of these bacteria. Although some progress have been achieved on the knowledge of the pathogenesis traits and virulence factors used by these bacteria, further work envisaging the identification of potential targets for the scientifically based design of new therapeutic strategies is urgently needed, due to the very difficult eradication of these bacteria with available therapies. An overview of these aspects of Bcc pathogenesis and opportunities for the design of future therapies is presented and discussed in this work.</abstract><cop>Berlin/Heidelberg</cop><pub>Berlin/Heidelberg : Springer-Verlag</pub><pmid>20390415</pmid><doi>10.1007/s00253-010-2528-0</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0175-7598 |
ispartof | Applied microbiology and biotechnology, 2010-06, Vol.87 (1), p.31-40 |
issn | 0175-7598 1432-0614 |
language | eng |
recordid | cdi_proquest_miscellaneous_746227803 |
source | MEDLINE; SpringerLink Journals - AutoHoldings |
subjects | Animals Antimicrobial agents Bacteria Biological and medical sciences Biomedical and Life Sciences Biotechnology Burkholderia cepacia Burkholderia cepacia complex Burkholderia cepacia complex - classification Burkholderia cepacia complex - drug effects Burkholderia cepacia complex - genetics Burkholderia cepacia complex - pathogenicity Burkholderia Infections - microbiology Burkholderia Infections - therapy Cystic fibrosis Disease Models, Animal Drug resistance Drug Resistance, Bacterial Enzymes Fundamental and applied biological sciences. Psychology Genomes Health aspects Humans Identification Infections Laboratories Life Sciences Microbial Genetics and Genomics Microbiology Mini-Review Pathogenesis Pathogenic microorganisms pathogenicity Pathogens Patients Plasmids Studies Taxonomy Virulence Virulence (Microbiology) Virulence Factors - antagonists & inhibitors Virulence Factors - genetics Virulence Factors - metabolism |
title | Pathogenicity, virulence factors, and strategies to fight against Burkholderia cepacia complex pathogens and related species |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-21T17%3A52%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pathogenicity,%20virulence%20factors,%20and%20strategies%20to%20fight%20against%20Burkholderia%20cepacia%20complex%20pathogens%20and%20related%20species&rft.jtitle=Applied%20microbiology%20and%20biotechnology&rft.au=Leit%C3%A3o,%20Jorge%20H&rft.date=2010-06-01&rft.volume=87&rft.issue=1&rft.spage=31&rft.epage=40&rft.pages=31-40&rft.issn=0175-7598&rft.eissn=1432-0614&rft.coden=AMBIDG&rft_id=info:doi/10.1007/s00253-010-2528-0&rft_dat=%3Cgale_proqu%3EA623955049%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=304618603&rft_id=info:pmid/20390415&rft_galeid=A623955049&rfr_iscdi=true |